SK Biopharmaceuticals, Eurofarma to set up AI epilepsy platform JV in US

South Korea’s SK Biopharmaceuticals Co. has signed a deal with Brazil’s Eurofarma Laboratórios S.A. to establish a joint venture ...

SK Group’s 3rd-generation daughter comes to the fore

Chey Yoon-chung, the eldest daughter of SK Group Chairman Chey Tae-won, unexpectedly made her debut during an SK Biopharmaceuticals Co. video confer...

SK Biopharm mulls acquiring firms, drug sales rights in US

SAN DIEGO, California -- South Korea’s SK Biopharmaceuticals Co. is considering acquiring firms in the US, or the sales rights to some of thei...

OCI eyes acquisition of US biopharmaceutical company

OCI Holdings Co., South Korea’s largest polysilicon maker, is looking abroad to acquire a biopharmaceutical company in the US in a consortium,...

Korea’s Celltrion, SK Biopharmaceuticals benefit from direct US sales

Celltrion Inc. and SK Biopharmaceuticals Co. are witnessing improving sales revenue and profitability by selling their products through their own ma...

Aprogen gets OK Phase 3 trials in India for Herceptin biosimilar

South Korea’s biopharmaceutical company Aprogen Inc. announced on Monday that its Phase 3 clinical trial for a biosimilar of Herceptin (trastu...

LegoChem Bio mulls name change after defeat to Lego

South Korean biopharmaceutical company LegoChem Biosciences Inc. is seeking to change its name after it lost in a trademark infringement lawsuit fil...

SK Biopharmaceuticals forms Scientific Advisory Board

South Korea's SK Biopharmaceuticals assembled its Scientific Advisory Board (SAB) composed of world-renowned physicians and drug development experts...

SK Biopharmaceuticals gets OK to sell epilepsy drug in Canada

South Korea's SK Biopharmaceuticals has received approval in Canada to sell its new epilepsy drug Cenobamate under the product name Xcopri. Having e...

S.Korea’s SK to buy US bio JV stake from Roivant for $48 mn

SK Group, South Korea’s second-largest conglomerate, is set to purchase the entire stake in a US bio joint venture held by its partner, as the...

Celltrion applies for approval in US for eye treatment biosimilar

South Korean biopharmaceutical company Celltrion Inc. on Friday said it applied for approval from the US Food and Drug Administration (FDA) for CT-P...

SK Biopharmaceuticals gets marketing approval for epilepsy drug in Israel

South Korea’s SK Biopharmaceuticals said on Wednesday that the Israeli Ministry of Health has approved the company's new drug application (NDA...

Celltrion Healthcare enters top 10 in hospital prescriptions in Turkey

South Korean biopharmaceutical company Celltrion Healthcare Co. on Thursday said it ranked in the top 10 out of 400 companies last year on the Turki...

GeneOne Life Science gets patent for coated microneedle tech in China

South Korea’s biopharmaceutical company GeneOne Life Science Inc. on Tuesday said it received a patent from the China National Intellectual Pr...

SK Biopharmaceuticals wins Red Dot award for 2 devices

South Korea’s SK Biopharmaceuticals on Tuesday said two of its self-developed wearable devices won the main prize in the health care category ...

Celltrion teams up with bio venture to develop new anti-cancer drug

South Korea's biopharmaceutical company Celltrion Inc. will develop an anti-cancer drug that combines oncolytic virus technology with biosimilars un...

Dubai delegation conducts due diligence on Medytox's plant in Korea

South Korea's biopharmaceutical firm Medytox Inc. said on Monday that a high-level delegation led by Dubai Science Park (DSP) under Dubai's state-ow...

Samsung Biologics CEO focuses on global business

John Rim, chief executive of Samsung BioLogics will directly lead his company's global sales operations for biopharmaceuticals through contract deve...

SK bio families to present visions to global investors at SK Bio Night

SK Inc., the investment company of SK Group, said on Tuesday that it will hold a networking event called "SK Bio Night" in the US along with its bio...

Kolon signs MOU with Hanyang Univ. to develop gene therapy treatments

Kolon Industries Inc.'s Future Technology Institute said on Thursday that it had signed a memorandum of understanding with the Hanyang University In...

S.Korean biopharmaceutical sector to see brisk M&As in H1, 2023

An expert says the first half of next year will see the start of brisk M&As in biopharmaceuticals targeting strategic investors.Pyeon Jae-seong,...

SK Biopharmaceuticals launches epilepsy drug in France

South Korean SK Biopharmaceuticals Co. said on Friday that its treatment of epilepsy "Cenobamate" has been approved for sale in France.The company l...

SK Biopharmaceuticals to make CES debut in January

SK Biopharmaceuticals will take part in CES 2023, the world's largest trade show for IT and electronics held in Las Vegas, to unveil its medical dev...

SK Biopharmaceuticals signs epilepsy drug deal with Brazil’s Eurofarma

South Korea’s SK Biopharmaceuticals Co. has signed a deal to license out its technology for Cenobamate, an antiepileptic drug, to Brazil&rsquo...

SK invests in US digital healthcare firm Cala Health

South Korea's SK Biopharmaceuticals Co. has dipped its toes into the rapidly growing digital healthcare market by investing in Cala Health, a US-bas...

SK Chemicals to invest $1.6 bn in green, biopharmaceutical sectors

South Korea’s SK Chemicals plans to invest more than 2 trillion won ($1.6 billion) in eco-friendly material and biopharmaceutical businesses.T...